$79.24
0.68% yesterday
NYSE, Nov 21, 10:10 pm CET
ISIN
US92276F1003
Symbol
VTR

Ventas Stock News

Negative
Seeking Alpha
4 days ago
The REIT sector has seen back-to-back tough months as it saw a modest average negative total return in September (-0.73%) and fell deeper into the red in October (-4.03%). Small cap REITs (-5.05%) had the worst performance in October. Micro caps (-2.81%), mid caps (-3.11%) and large caps (-4.45%) were also in negative territory albeit to a smaller degree. Only 21.66% of REIT securities had a po...
Neutral
Business Wire
5 days ago
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research and Chief Executive Officer of Lillibridge Healthcare Services, has informed the Company of his intention to retire on May 1, 2026. Ventas will commence a search process to identify a successor. “Pete has been instrument...
Negative
Seeking Alpha
18 days ago
US equity real estate investment trust indexes dropped during the final week of October. The Dow Jones Equity All REIT index closed the recent week down 3.29%, while the MSCI US REIT (RMZ) index fell 2.88%. The healthcare REIT index was the sole Dow Jones US real estate property sector index to close the week in the black, recording a 1.47% gain.
Neutral
Seeking Alpha
22 days ago
Ventas, Inc. ( VTR ) Q3 2025 Earnings Call October 30, 2025 10:00 AM EDT Company Participants Bill Grant - Senior Vice President of Investor Relations Debra Cafaro - Chairman & CEO J. Hutchens - Executive VP of Senior Housing & Chief Investment Officer Robert Probst - Executive VP & CFO Peter Bulgarelli - Executive Vice President of Outpatient Medical & Research Conference Call Participants Jon...
Neutral
Business Wire
23 days ago
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2025. CEO Remarks “Ventas delivered strong financial performance and growth in the third quarter as we continued to execute on our 1-2-3 strategy. Results in the quarter were powered by our senior housing operating portfolio (SHOP), which experienced br...
Positive
Seeking Alpha
about one month ago
Ventas is a leading healthcare REIT, poised for growth due to rising senior housing demand and a strategic focus on the SHOP segment. Only WELL is the major competitor in SHOP, while the others are betting on other types of segments and triple-net leasing. Despite trading at a premium (20x P/FFO), VTR offers a compelling total return thesis, targeting a 25% upside to $86.50 and dividend growth ...
Neutral
Business Wire
about 2 months ago
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its third quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, October 29, 2025. A conference call to discuss those earnings will be held on Thursday, October 30, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or ...
Positive
Market Watch
2 months ago
Gains haven't been limited to the companies at the top of the S&P 500.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today